Articles Pharma Articles Vaccination Articles Virology Articles

SARS-CoV-2 Isolation and Propagation from Turkish COVID-19 Patients

Publish time: 24 April 2020

Authors: Cihan TastanBulut YurtseverGozde SirDerya Dilek Kancagi, Sevda Demir, Selen Abanuz, Utku Seyis, Mulazim Yildirim, Recai Kuzay, Omer Elibol, Serap Arbak, Merve Acikel Elmas, Selcuk Birdogan, Eray SahinOrhan Ozcan, Ugur Sezerman, Ercument Ovali

Keywords:  COVID-19, SARS-CoV-2, Coronavirus


The novel coronavirus pneumonia, which was named later as Coronavirus Disease 2019 (COVID-19), is caused by the Severe Acute Respiratory Syndrome Coronavirus 2, namely SARS-CoV-2. It is a positive-strand RNA virus that is the seventh coronavirus known to infect humans. The COVID-19 outbreak presents enormous challenges for global health behind the pandemic outbreak. The first diagnosed patient in Turkey has been reported by the Republic of Turkey Ministry of Health on March 11, 2020. Today, over eight thousand cases in Turkey and two million cases around the world have been declared. Due to the urgent need for vaccine studies and drug discoveries, isolation of the virus is crucial. Here, we report one of the first isolation and characterization studies of SARS-CoV-2 from nasopharyngeal and oropharyngeal specimens of diagnosed patients in Turkey. This study suggests replication methodology and cell culture tropism of the virus that will be available to the research communities.

SARS-CoV-2 Isolation and Propagation from Turkish COVID-19 Patients



Leave a Comment